Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$104.03
-0.4%
$103.89
$81.97
▼
$129.85
$180.95B0.548.33 million shs7.51 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.00
-1.5%
$43.85
$39.57
▼
$101.91
$63.26B0.619.94 million shs15.92 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.44%-2.98%+1.31%-10.80%-17.62%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-1.59%-2.76%-5.69%-14.66%-55.69%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$104.03
-0.4%
$103.89
$81.97
▼
$129.85
$180.95B0.548.33 million shs7.51 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.00
-1.5%
$43.85
$39.57
▼
$101.91
$63.26B0.619.94 million shs15.92 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.44%-2.98%+1.31%-10.80%-17.62%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-1.59%-2.76%-5.69%-14.66%-55.69%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.93
Moderate Buy$119.0414.43% Upside
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.65
Moderate Buy$61.4342.86% Upside

Current Analyst Ratings Breakdown

Latest ABT and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/19/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
UpgradeMarket Perform ➝ Outperform$124.00
10/30/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetEqual Weight$48.00 ➝ $45.00
10/30/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
DowngradeBuy ➝ Hold$56.00 ➝ $46.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$70.00 ➝ $52.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Set Price TargetBuy$60.00 ➝ $48.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$70.00 ➝ $52.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetNeutral$48.00 ➝ $44.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$55.00 ➝ $50.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Set Price Target$55.00 ➝ $50.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetBuy$66.00 ➝ $48.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$54.00 ➝ $49.00
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B4.06$6.96 per share14.94$29.81 per share3.49
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.11$3.98 per share10.81$17.85 per share2.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$2.6819.4217.571.839.75%18.04%9.09%1/28/2027 (Estimated)
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.3613.6813.921.2916.62%18.61%10.58%2/3/2027 (Estimated)

Latest ABT and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/28/2026Q3 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.7270$0.73+$0.0030$0.40$5.09 billion$5.14 billion
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.42%+10.39%94.03%54 Years
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A

Latest ABT and BSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.45
1.00
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.42
1.36
0.81

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable

Recent News About These Companies

Why You Should Think About Boston Scientific Differently Now
Boston Scientific: A Longer Road To Recovery (Rating Downgrade)
RxSight (NASDAQ:RXST) vs. Boston Scientific (NYSE:BSX) Financial Comparison
Bear of the Day: Boston Scientific (BSX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$104.03 -0.45 (-0.43%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$104.27 +0.25 (+0.24%)
As of 11/19/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$43.00 -0.64 (-1.46%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$42.96 -0.04 (-0.10%)
As of 11/19/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.